Volume | 42,076 |
|
|||||
News | - | ||||||
Day High | 7.60 | Low High |
|||||
Day Low | 7.25 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Profound Medical Corporation | PROF | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.44 | 7.25 | 7.60 | 7.25 | 7.45 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
315 | 42,076 | US$ 7.47 | US$ 314,360 | - | 7.11 - 15.49 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 1 | US$ 7.35 | USD |
Profound Medical Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
213.23M | 21.37M | - | 7.2M | -28.57M | -1.34 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Profound Medical News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROF Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.43 | 7.6074 | 7.25 | 7.40 | 23,553 | -0.18 | -2.42% |
1 Month | 7.38 | 8.92 | 7.25 | 7.81 | 26,689 | -0.13 | -1.76% |
3 Months | 8.00 | 8.92 | 7.25 | 7.95 | 25,496 | -0.75 | -9.38% |
6 Months | 10.72 | 10.856 | 7.11 | 8.24 | 44,219 | -3.47 | -32.37% |
1 Year | 13.87 | 15.49 | 7.11 | 9.25 | 32,423 | -6.62 | -47.73% |
3 Years | 17.61 | 19.32 | 3.10 | 10.07 | 47,549 | -10.36 | -58.83% |
5 Years | 9.98 | 28.97 | 3.10 | 13.26 | 55,490 | -2.73 | -27.35% |
Profound Medical Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner. |